The Europe diabetes care devices market is anticipated to reach a substantial value of USD 15.11 billion by the year 2030, demonstrating a compound annual growth rate (CAGR) of 7.0% throughout the forecast period, as detailed in a recent report by Grand View Research, Inc. The significant size of this market is supported by the substantial contributions from well-established European economies, including Germany, the U.K., France, and Italy. The prevalence of diabetes is on the rise across all age groups within European countries, primarily attributable to factors such as unhealthy lifestyles, increasing rates of obesity and overweight individuals, and physical inactivity. According to data from the International Diabetes Federation (IDF), approximately 66.0 million people in Europe are currently living with diabetes, and this number is projected to increase to around 81.0 million by the year 2045. Consequently, the expanding diabetes population base within this region is expected to be a major driving force for the growth of the Europe diabetes devices market.

Furthermore, the region is projected to experience a high growth rate during the forecast period, fueled by continuous efforts aimed at diabetes control by both governmental bodies and healthcare organizations such as the IDF. These organizations play a crucial role in providing necessary expertise and supporting diabetes awareness campaigns through their extensive network of stakeholders and partners. Additionally, the increasing allocation of funding towards healthcare within the region is anticipated to further propel the market's growth trajectory.

Moreover, the growing geriatric population in Europe is also expected to significantly contribute to the market's expansion over the forecast period. In 2018, nearly one-fifth of Europe's total population was aged 65 years or older, a demographic trend that is further fueling the demand for diabetes care devices. According to the United Nations report on World Population Aging, the older population in Europe is projected to constitute a substantial 35.0% of the total population by the year 2050. In addition to these demographic and healthcare-related factors, leading manufacturers in the market are increasingly focusing on technological innovations and the development of advanced products to capture a significant share of the market.

Curious about the Europe Diabetes Care Devices Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Europe Diabetes Care Devices Market Report Highlights include:

• The Germany diabetes care device market is anticipated to experience rapid growth throughout the forecast period. This accelerated growth is attributed to favorable reimbursement policies within the country, the local presence of key market players, and supportive initiatives implemented by the German government aimed at improving diabetes care.

• Blood glucose monitoring (BGM) devices are expected to register significant growth over the forecast period, with a projected compound annual growth rate (CAGR) of 6.5%. This indicates a sustained demand for devices that allow individuals to effectively monitor their blood sugar levels.

• In the year 2023, Hospital pharmacies dominated the market for diabetes care devices in Europe, accounting for a substantial revenue share of 54.1%. This highlights the significant role of hospital-based pharmacies in the distribution of these essential medical devices.

• The insulin pumps segment is expected to experience growth during the forecast period. This growth is primarily driven by the inherent advantages of insulin pumps, such as the reduced need for frequent injections to deliver insulin, offering a more convenient and potentially more effective method of insulin delivery for many individuals with diabetes.

List of Key Players in the Europe Diabetes Care Devices Market

• Medtronic plc

• Abbott Laboratories

• F. Hoffmann-La Roche Ltd.

• Bayer AG

• LifeScan IP Holdings, LLC

• B. Braun Melsungen AG

• Dexcom, Inc.

• Insulet Corporation

• Ypsomed Holding AG

• Companion Medical, Inc.

• Sanofi S.A.

• Valeritas Holdings, Inc.

• Novo Nordisk A/S

• Arkray, Inc.

Order a free sample PDF of the Europe Diabetes Care Devices Market Intelligence Study, published by Grand View Research.